Home
>
US Stocks
>
LAVA Therapeutics NV
LAVA Therapeutics NV
LVTX

LAVA Therapeutics NV

$7.172.14%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
7.89
Today Low/High
7.14 / 7.89
52 Week Low/High
$5.5 / $17.2
Market Cap
$146.79M

Company Details

LAVA Therapeutics N.V. is a biotechnology company developing a portfolio of bispecific gamma-delta T cell engagers (gamma-delta bsTCEs) for the treatment of solid tumors and hematologic malignancies based on its proprietary platform. The company’s innovative approach leverages bispecific antibodies to activate Vγ9Vδ2 T cells upon binding to membrane-expressed tumor associated antigens. Activated Vγ9Vδ2 T cells are engaged for direct, selective tumor cell killing. The company’s lead program, LAVA-051, is expected to enter a Phase 1/2a clinical study in hematologic malignancies in the first half of 2021. The company has established a highly experienced research and development team located in Utrecht, the Netherlands and Philadelphia, USA.
Organisation
LAVA Therapeutics NV

Discover more

Frequently Asked Questions

What is LAVA Therapeutics NV share price today

Can Indians buy LAVA Therapeutics NV shares?

How can I buy LAVA Therapeutics NV shares from India?

Can Fractional shares of LAVA Therapeutics NV be purchased?

What are the documents required to start investing in LAVA Therapeutics NV stocks?

We are a SEBI registered investement advisor